A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Clinical trial NCT05869955 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05869955
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathy Systemic Sclerosis Rheumatoid Arthritis

Start date: 2023-09-13
Primary completion: 2028-08-29
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.